Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(36:5e)/PE(36:4p) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 328 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 413 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 424 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 86.6 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 92.7 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 93.6 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 605 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 670 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | C | 0.0 | BCD100322A01 | 168 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | C | 0.5 | BCD100322A03 | 456 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | C | 1.0 | BCD100322A07 | 558 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | C | 2.0 | BCD100322A11 | 632 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | C | 4.0 | BCD100322A15 | 85.6 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | C | 8.0 | BCD100322A19 | 98.4 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | C | 12.0 | BCD100322A23 | 108 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | C | 24.0 | BCD100322A27 | 747 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 493 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 571 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 228 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 84.6 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 88.9 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 577 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 719 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol | 0.5 | BCD100322A04 | 423 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol | 1.0 | BCD100322A08 | 639 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol | 2.0 | BCD100322A12 | 131 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol | 4.0 | BCD100322A16 | 104 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol | 8.0 | BCD100322A20 | 91.1 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol | 12.0 | BCD100322A24 | 85.9 | pmol/sample |
| - | PE(36:5e)/PE(36:4p) | 25OH-Chol | 24.0 | BCD100322A28 | 852 | pmol/sample |